[SLRX] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
05-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 22.59%
YoY- -53.48%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 0 0 0 0 0 -1,840 0 -
PBT -5,341 -6,371 -14,409 -4,718 -6,109 -4,105 -3,737 26.90%
Tax -80 111 -78 -38 -14 -44 -10 300.50%
NP -5,261 -6,482 -14,331 -4,718 -6,095 -4,105 -3,737 25.63%
Tax Rate - - - - - - - -
Total Cost 5,261 6,482 14,331 4,718 6,095 2,265 3,737 25.63%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 223.06 0.00 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -2.20 -2.88 -6.38 -2.20 -3.29 -2.27 -2.09 3.48%
EPS Diluted -2.20 -2.88 -6.38 -2.20 -3.29 -2.27 -2.09 3.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.